Pharmaceutical

Olanzapine by Neurelis for Bipolar Disorder (Manic Depression): Likelihood of Approval

Olanzapine is under clinical development by Neurelis and currently in Phase I for Bipolar Disorder (Manic Depression).

Jun 18, 2024 - 04:00
Olanzapine is under clinical development by Neurelis and currently in Phase I for Bipolar Disorder (Manic Depression).
Read the original article

Tags:

Previous Article

Can supermarket pharmacies plug urgent healthcare gaps?

Next Article

Omalizumab biosimilar by Teva Pharmaceutical Industries for Chronic Urticaria Or...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: House committee hearing kicks off potential doctor pay reforms in Medicare

STAT+: House committee hearing kicks off potential doct...

Oct 20, 2023

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound

Eli Lilly gets FDA approval to sell Mounjaro as obesity...

Nov 9, 2023

Academia’s postdoc system is teetering, imperiling efforts to diversify life sciences

Academia’s postdoc system is teetering, imperiling effo...

Jun 6, 2023